Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cataract > Cataract surgery linked to modest increase in neovascular AMD conversion risk
  • Cataract

Cataract surgery linked to modest increase in neovascular AMD conversion risk

Ophthalmology 360

Key Takeaways

  1. Cataract surgery was associated with a 22% higher overall risk of conversion from dry age-related macular degeneration to neovascular AMD.

Patients with dry age-related macular degeneration (AMD) who underwent cataract surgery had a modestly higher risk of progressing to neovascular AMD (wet AMD) compared with those who did not undergo surgery, according to an IRIS Registry study. However, the increased risk was most pronounced shortly after surgery and diminished over time.

Researchers analyzed 80,106 matched eyes from patients aged 55 years and older with early or intermediate dry AMD, including 40,053 eyes that underwent cataract surgery and an equal number that did not.

Cataract surgery was associated with a 22% increased risk of progression to wet AMD (P < 0.001).

The increased risk was most pronounced during the first year after cataract surgery, when the likelihood of conversion to nvAMD was approximately 2.5-fold higher. The association weakened over time and was no longer statistically significant by year 4. After 6 years of follow-up, the cumulative incidence of nvAMD was 17.7% in eyes that underwent cataract surgery versus 15.2% in eyes that did not.

The relationship between cataract surgery and progression to nvAMD varied by baseline AMD stage, with a weaker association observed in eyes with intermediate AMD.

The researchers noted that the time-dependent pattern may reflect increased surveillance or previously unrecognized nvAMD rather than a lasting effect of cataract surgery itself.

Reference
Ashourizadeh H, Gilbert JB, Ross C, et al; IRIS® Registry Analytic Center Consortium. Cataract Surgery and the Risk of Conversion from Dry to Neovascular Age-related Macular Degeneration in the IRIS© Registry. Ophthalmology. 2026;S0161-6420(26)00420-3. doi: 10.1016/j.ophtha.2026.06.016. Epub ahead of print. PMID: 42331067.

Share

Related Content

  • Cataract

Cataract surgery complication rates unaffected by surgeon-patient sex concordance

  • General

Preserflo associated with fewer complications than Xen63 in glaucoma surgery

  • Cataract

Optimizing cataract surgery outcomes through dry eye management

  • Cataract

Spotlight on TECNIS Odyssey™

  • General

Glaucoma may signal complications in intraocular cancers, review suggests

  • Cataract

IOL exchange shows highest success for dissatisfaction after presbyopia-correcting lens surgery

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon